Published May 2019
| Version v1
Journal article
First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial Sub-Study
Creators
- 1. Interventional Cardiology Department, MedStar Washington Hospital Center, Washington, DC (United States)
- 2. Medical Clinic I, Städtische Kliniken Neuss, Lukaskrankenhaus GmbH, Neuss (Germany)
- 3. Deutsches Herzzentrum Muenchen und Deutsches Zentrum fuer Herz-Kreislaufforschung e.V., Munich (Germany)
- 4. Cardiologie, Catharina Ziekenhuis, Eindhoven, the (Netherlands)
Description
The edge vascular response (EVR) remains unknown in second generation drug-eluting Resorbable Magnesium Scaffold (RMS), such as Magmaris. The aim of the study was to evaluate tissue modifications in the RMS edges over time, assessed by different invasive imaging modalities.
Additional details
Identifiers
- DOI
- 10.1016/j.carrev.2019.02.019;
- PII
- S1553838919301526;
Publishing Information
- Journal Title
- Cardiovascular Revascularization Medicine (Print)
- Journal Volume
- 20
- Journal Issue
- 5
- Journal Page Range
- p. 392-398
- ISSN
- 1553-8389
INIS
- Country of Publication
- Netherlands
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 55055921
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ANIMAL TISSUES; CARDIOVASCULAR DISEASES; DRUGS; HISTOLOGY; TOMOGRAPHY
- Descriptors DEC
- BODY; DIAGNOSTIC TECHNIQUES; DISEASES
Optional Information
- Copyright
- Copyright (c) 2019 Elsevier Inc. All rights reserved.